Tag tamoxifen [137 articles] Export

Recent papers classified by the tag tamoxifen.

	Biological determinants of endocrine resistance in breast cancer [My Copy] Nature Reviews Cancer, Vol. 9, No. 9. (01 September 2009), pp. 631-643. by Elizabeth A. Musgrove, Robert L. Sutherland posted to tamoxifen review drug_resistant breast_cancer by tonamswish on 2009-12-11 17:12:51 as along with 2 people songpku misonneh
	Pathways to tamoxifen resistance. [My Copy] Cancer letters, Vol. 256, No. 1. (18 October 2007), pp. 1-24. by Rebecca B. Riggins, Randy S. Schrecengost, Michael S. Guerrero, Amy H. Bouton posted to tamoxifen review pathway breast_cancer by tonamswish on 2009-12-11 17:07:10 as
	A candidate molecular signature associated with tamoxifen failure in primary breast cancer. [My Copy] Breast cancer research : BCR, Vol. 10, No. 5. (17 October 2008), R88. by Julie A. Vendrell, Katherine E. Robertson, Patrice Ravel, et al.Susan E. Bray, Agathe Bajard, Colin A. Purdie, Catherine Nguyen, Sirwan M. Hadad, Ivan Bieche, Sylvie Chabaud, Thomas Bachelot, Alastair M. Thompson, Pascale A. Cohen posted to tamoxifen mrnaarray geo gene_signature gene_expression_signature breast_cancer by tonamswish on 2009-12-11 17:03:05 as along with 3 people and 1 group jfr erexhepa Zephyrus Breast Cancer Reading Club
	Molecular Changes in Tamoxifen-Resistant Breast Cancer: Relationship Between Estrogen Receptor, HER-2, and p38 Mitogen-Activated Protein Kinase [My Copy] J Clin Oncol, Vol. 23, No. 11. (10 April 2005), pp. 2469-2476. by M. Carolina Gutierrez, Simone Detre, Stephen Johnston, et al.Syed K. Mohsin, Jiang Shou, D. Craig Allred, Rachel Schiff, C. Kent Osborne, Mitch Dowsett posted to tamoxifen review pathway p38 mapk her2 erbb2 breast_cancer by tonamswish on 2009-12-11 16:57:56 as along with 1 person jfr
	Identification of Functional Networks of Estrogen- and c-Myc-Responsive Genes and Their Relationship to Response to Tamoxifen Therapy in Breast Cancer [My Copy] PLoS ONE, Vol. 3, No. 8. (20 August 2008), e2987. by Elizabeth A. Musgrove, C. Marcelo Sergio, Sherene Loi, et al.Claire K. Inman, Luke R. Anderson, M. Chehani Alles, Mark Pinese, C. Elizabeth Caldon, Judith Schütte, Margaret Gardiner-Garden, Christopher J. Ormandy, Grant McArthur, Alison J. Butt, Robert L. Sutherland posted to tamoxifen myc mrnaarray gene_expression_signature estrogen cmyc breast_cancer by tonamswish on 2009-12-11 16:18:22 as
	Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. [My Copy] British journal of cancer, Vol. 71, No. 4. (April 1995), pp. 854-856. by P. Lissoni, S. Barni, S. Meregalli, et al.V. Fossati, M. Cazzaniga, D. Esposti, G. Tancini posted to therapeutic tamoxifen lissoni by estmelbrca on 2009-12-07 11:03:57 as
	Understanding resistance to tamoxifen in hormone receptor-positive breast cancer. [My Copy] Clinical chemistry, Vol. 55, No. 8. (August 2009), pp. 1453-1455. by Michaela J. Higgins, Vered Stearns posted to tamoxifen review pax2 pathway her2 errb2 er drug_resistent by tonamswish on 2009-12-03 15:30:47 as
	Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer. [My Copy] Carcinogenesis, Vol. 29, No. 7. (July 2008), pp. 1459-1465. by Benjamin A. Rodriguez, Alfred S. Cheng, Pearlly S. Yan, et al.Dustin Potter, Francisco J. Agosto-Perez, Charles L. Shapiro, Tim H-M H. Huang posted to tamoxifen polycomb phenotype moa estrogen epigenetics breast by misonneh on 2009-11-24 06:51:57 as
	Providing accurate information to women about tamoxifen therapy for breast cancer: current indications, effects, and controversies. [My Copy] Oncology nursing forum, Vol. 25, No. 9. (October 1998), pp. 1577-1583. by J. V. Pasacreta, R. McCorkle posted to tempreg tamoxifen hot_flash brca by kathleenkokolus on 2009-11-23 18:50:03 as
	Symptoms associated with tamoxifen treatment in postmenopausal women. [My Copy] Archives of internal medicine, Vol. 151, No. 9. (September 1991), pp. 1842-1847. by R. R. Love, L. Cameron, B. L. Connell, H. Leventhal posted to tempreg tamoxifen hot_flash by kathleenkokolus on 2009-11-23 18:47:32 as
	Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects [My Copy] J Clin Oncol, Vol. 7, No. 6. (1 June 1989), pp. 803-815. by R. R. Love posted to tempreg tamoxifen hot_flash brca by kathleenkokolus on 2009-11-23 18:43:58 as
	Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen [My Copy] JAMA, Vol. 302, No. 13. (7 October 2009), pp. 1429-1436. by Werner Schroth, Matthew P. Goetz, Ute Hamann, et al.Peter A. Fasching, Marcus Schmidt, Stefan Winter, Peter Fritz, Wolfgang Simon, Vera J. Suman, Matthew M. Ames, Stephanie L. Safgren, Mary J. Kuffel, Hans U. Ulmer, Julia Bolander, Reiner Strick, Matthias W. Beckmann, Heinz Koelbl, Richard M. Weinshilboum, James N. Ingle, Michel Eichelbaum, Matthias Schwab, Hiltrud Brauch posted to tamoxifen polymorphism pharmacogenetics cyp2d6 cancer breast by songpku on 2009-11-22 22:54:50 as along with 2 people misonneh merpublic
	MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. [My Copy] The Journal of biological chemistry, Vol. 283, No. 45. (7 November 2008), pp. 31079-31086. by Jian-Jun J. Zhao, Jianhong Lin, Hua Yang, et al.William Kong, Lili He, Xu Ma, Domenico Coppola, Jin Q. Cheng posted to tamoxifen bc 7 5 by calvin on 2009-11-19 21:25:00 as along with 1 person songpku
	MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1 [My Copy] Journal of Biological Chemistry, Vol. 283, No. 44. (31 October 2008), pp. 29897-29903. by Tyler E. Miller, Kalpana Ghoshal, Bhuvaneswari Ramaswamy, et al.Satavisha Roy, Jharna Datta, Charles L. Shapiro, Samson Jacob, Sarmila Majumder posted to tamoxifen resistance mirna microrna cancer breast by songpku on 2009-11-19 21:19:16 as along with 1 person and 1 group jfr microRNA
	Genetic matters of CYP2D6 in breast cancer: copy number variations and nucleotide polymorphisms [My Copy] Nat Rev Cancer, Vol. 9, No. 11. (23 October 2009), pp. 842-843. by Ke-Da Yu, Zhi-Ming Shao posted to tamoxifen review pharmacogenetics genetics cyp2d6 comments breast by misonneh on 2009-11-19 05:26:25 as
	Identification of novel ER-α target genes in breast cancer cells: Gene- and cell-selective co-regulator recruitment at target promoters determines the response to 17β-estradiol and tamoxifen [My Copy] Molecular and Cellular Endocrinology, Vol. 314, No. 1. (15 January 2010), pp. 90-100. by Andrea Romano, Michiel Adriaens, Sabine Kuenen, et al.Bert Delvoux, Gerard Dunselman, Chris Evelo, Patrick Groothuis posted to tamoxifen era_target era er drug_resistent breast_cancer by tonamswish on 2009-11-13 22:53:37 as along with 1 person Zephyrus
	Genetic polymorphisms of CYP2D6 10 and CYP2C19 2, 3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen. [My Copy] Cancer, Vol. 115, No. 5. (1 March 2009), pp. 952-961. by Masatsugu Okishiro, Tetsuya Taguchi, Seung Jin Kim, Kenzo Shimazu, Yasuhiro Tamaki, Shinzaburo Noguchi posted to tamoxifen pharmacogenetics cyp2d6 breast asian_populations by misonneh on 2009-10-27 07:17:16 as along with 2 people ilsun Mi-Seon
	Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. [My Copy] Journal of the National Cancer Institute, Vol. 95, No. 23. (3 December 2003), pp. 1758-1764. by Vered Stearns, Michael D. Johnson, James M. Rae, et al.Alan Morocho, Antonella Novielli, Pankaj Bhargava, Daniel F. Hayes, Zeruesenay Desta, David A. Flockhart posted to tamoxifen pk pharmacogenetics metabolism ddi breast by misonneh on 2009-10-27 07:02:30 as
	CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. [My Copy] Journal of the National Cancer Institute, Vol. 97, No. 1. (5 January 2005), pp. 30-39. by Yan Jin, Zeruesenay Desta, Vered Stearns, et al.Bryan Ward, Herbert Ho, Kyung-Hoon H. Lee, Todd Skaar, Anna Maria M. Storniolo, Lang Li, Adjei Araba, Rebecca Blanchard, Anne Nguyen, Lynda Ullmer, Jill Hayden, Suzanne Lemler, Richard M. Weinshilboum, James M. Rae, Daniel F. Hayes, David A. Flockhart posted to tamoxifen pharmacogenetics genetics ddi cyp2d6 breast by misonneh on 2009-10-27 07:01:49 as along with 1 person frohike
	Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment. [My Copy] Clinical pharmacology and therapeutics, Vol. 80, No. 1. (July 2006), pp. 61-74. by Silvana Borges, Zeruesenay Desta, Lang Li, et al.Todd C. Skaar, Bryan A. Ward, Anne Nguyen, Yan Jin, Anna Maria M. Storniolo, D. Michele Nikoloff, Lin Wu, Grant Hillman, Daniel F. Hayes, Vered Stearns, David A. Flockhart posted to tamoxifen pk pharmacogenetics metabolism cyp2d6 breast by misonneh on 2009-10-27 07:01:06 as
	Germline pharmacogenetics of tamoxifen response: have we learned enough? [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 25, No. 33. (20 November 2007), pp. 5147-5149. by Zeruesenay Desta, David A. Flockhart posted to tamoxifen pharmacogenetics genetics cyp2d6 comments breast by misonneh on 2009-10-27 06:59:30 as
	Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy. [My Copy] Breast cancer research and treatment, Vol. 115, No. 3. (June 2009), pp. 643-650. by Adedayo A. Onitilo, Catherine A. McCarty, Russell A. Wilke, et al.Ingrid Glurich, Jessica M. Engel, David A. Flockhart, Anne Nguyen, Lang Li, Deming Mi, Todd C. Skaar, Yan Jin posted to tamoxifen pharmacogenetics hr genetics breast adr by misonneh on 2009-10-21 02:21:36 as
	Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients [My Copy] Breast Cancer Research and Treatment, Vol. 91, No. 3. (28 June 2005), pp. 249-258. by Susan A. Nowell, Jiyoung Ahn, James M. Rae, et al.Joshua O. Scheys, Andrew Trovato, Carol Sweeney, Stewart L. MacLeod, Fred F. Kadlubar, Christine B. Ambrosone posted to tamoxifen pharmacogenetics cyp2d6 cancer breast by songpku on 2009-10-19 21:58:35 as along with 2 people Mi-Seon frohike
	Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents. [My Copy] Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 17, No. 2. (February 2006), pp. 200-204. by I. Vergote, P. Abram posted to tamoxifen cancer_therapy breast_cancer by ekotelnikova on 2009-10-08 20:08:07 as
	Tamoxifen resistance and epigenetic modifications in breast cancer cell lines. [My Copy] Current medicinal chemistry, Vol. 14, No. 28. (2007), pp. 3035-3045. by E. Badia, J. Oliva, P. Balaguer, V. Cavaillès posted to tamoxifen resistance epigenetics cancer breast by Zephyrus on 2009-10-08 08:09:08 as along with 1 person and 1 group misonneh Roswell Cancer Crosstalk
	Estrogen Receptor Genotypes Influence Hot Flash Prevalence and Composite Score Before and After Tamoxifen Therapy [My Copy] J Clin Oncol, Vol. 26, No. 36. (20 December 2008), pp. 5849-5854. by Yan Jin, Daniel F. Hayes, Lang Li, et al.Jason D. Robarge, Todd C. Skaar, Santosh Philips, Anne Nguyen, Anne Schott, Jill Hayden, Suzanne Lemler, Anna M. Storniolo, David A. Flockhart, Vered Stearns posted to tamoxifen hot-flash genotype estrogen-receptor cancer breast by Zephyrus on 2009-10-08 07:46:32 as along with 1 person and 2 groups songpku Roswell Cancer Crosstalk Breast Cancer Reading Club
	Relevance of Breast Cancer Antiestrogen Resistance Genes in Human Breast Cancer Progression and Tamoxifen Resistance [My Copy] J Clin Oncol (15 December 2008), JCO.2008.17.1462. by Ton van Agthoven, Anieta M. Sieuwerts, Meijer-Van, et al.Maxime P. Look, Marcel Smid, Jos Veldscholte, Stefan Sleijfer, John A. Foekens, Lambert C. Dorssers posted to tamoxifen resistance progression cancer breast by Zephyrus on 2009-10-07 08:01:41 as along with 2 people and 2 groups misonneh songpku Roswell Cancer Crosstalk Breast Cancer Reading Club
	Oral Clonidine in Postmenopausal Patients with Breast Cancer Experiencing Tamoxifen-Induced Hot Flashes: A University of Rochester Cancer Center Community Clinical Oncology Program Study [My Copy] Ann Intern Med, Vol. 132, No. 10. (16 May 2000), pp. 788-793. by Kishan J. Pandya, Richard F. Raubertas, Patrick J. Flynn, et al.Harry E. Hynes, Richard J. Rosenbluth, Jeffrey J. Kirshner, H. Irving Pierce, Vladimir Dragalin, Gary R. Morrow posted to tempreg tamoxifen hot_flash clonidine brca by kathleenkokolus on 2009-10-06 21:28:41 as
	Tamoxifen Inhibition of Estrogen Receptor-alpha-Negative Mouse Mammary Tumorigenesis [My Copy] Cancer Res, Vol. 65, No. 8. (15 April 2005), pp. 3493-3496. by Daniel Medina, Frances S. Kittrell, Jamal Hill, Anne Shepard, Gudmundur Thordarson, Powel Brown posted to tamoxifen involution era by kathleenkokolus on 2009-10-06 19:37:02 as along with 1 person Zephyrus
	Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth. [My Copy] Breast cancer research and treatment, Vol. 96, No. 2. (March 2006), pp. 131-146. by D. J. Britton, I. R. Hutcheson, J. M. Knowlden, et al.D. Barrow, M. Giles, R. A. McClelland, J. M. Gee, R. I. Nicholson posted to tamoxifen signaling er-alpha cancer breast by Zephyrus on 2009-09-28 17:29:16 as along with 2 people misonneh SChewchuk
	No Increase in Breast Cancer Recurrence with Concurrent Use of Tamoxifen and Some CYP2D6-Inhibiting Medications [My Copy] Cancer Epidemiology Biomarkers & Prevention, Vol. 18, No. 9. (September 2009), pp. 2562-2564. by Thomas P. Ahern, Lars Pedersen, Deirdre P. Cronin-Fenton, Henrik T. SÃ¸rensen, Timothy L. Lash posted to tamoxifen pharmacogenetics ddi cyp2d6 breast by misonneh on 2009-09-25 06:27:56 as
	ChIP-Seq of ER\|[alpha]\| and RNA polymerase II defines genes differentially responding to ligands [My Copy] EMBO J, Vol. 28, No. 10. (04 April 2009), pp. 1418-1428. by Willem-Jan Welboren, Marc A. van Driel, Eva M. Janssen-Megens, et al.Simon J. van Heeringen, Fred C. G. J. Sweep, Paul N. Span, Hendrik G. Stunnenberg posted to tamoxifen pol2 mcf7 era chip-seq bioinfo by tonamswish on 2009-09-20 03:48:16 as along with 1 person ewilban1
	Restoration of Tamoxifen Sensitivity in Estrogen Receptor-Negative Breast Cancer Cells: Tamoxifen-Bound Reactivated ER Recruits Distinctive Corepressor Complexes [My Copy] Cancer Res, Vol. 66, No. 12. (15 June 2006), pp. 6370-6378. by Dipali Sharma, Neeraj K. Saxena, Nancy E. Davidson, Paula M. Vertino posted to tamoxifen hdac er_negative breast_cancer by tonamswish on 2009-09-18 17:47:39 as
	Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo. [My Copy] The Journal of biological chemistry, Vol. 279, No. 15. (9 April 2004), pp. 15050-15058. by Xue-Feng F. Liu, Milan K. Bagchi posted to tamoxifen histone_modification era er breast_cancer by tonamswish on 2009-09-18 17:36:44 as
	Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. [My Copy] Nature (12 November 2008) by Antoni Hurtado, Kelly A A. Holmes, Timothy R R. Geistlinger, et al.Iain R R. Hutcheson, Robert I I. Nicholson, Myles Brown, Jie Jiang, William J J. Howat, Simak Ali, Jason S S. Carroll posted to tamoxifen response resistance estrogen-receptor cancer breast by Zephyrus on 2009-09-17 19:42:44 as along with 2 people and 2 groups jfr songpku Roswell Cancer Crosstalk Breast Cancer Reading Club
	Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells. [My Copy] Cancer research, Vol. 67, No. 3. (1 February 2007), pp. 1352-1360. by Ping Fan, Jiping Wang, Richard J. Santen, Wei Yue posted to tamoxifen resistance esr1 egfr_pathway breast by misonneh on 2009-09-08 07:16:38 as
	Adaptation to estradiol deprivation causes up-regulation of growth factor pathways and hypersensitivity to estradiol in breast cancer cells. [My Copy] Advances in experimental medicine and biology, Vol. 630 (2008), pp. 19-34. by Richard J. Santen, Robert X. Song, Shigeru Masamura, et al.Wei Yue, Ping Fan, Tetsuya Sogon, Shin-ichi Hayashi, Kei Nakachi, Hidtek Eguchi posted to tamoxifen review resistance moa estrogen breast by misonneh on 2009-09-08 07:14:52 as
	Mechanisms of tamoxifen-induced apoptosis. [My Copy] Apoptosis : an international journal on programmed cell death, Vol. 6, No. 6. (December 2001), pp. 469-477. by S. Mandlekar, A. N. Kong posted to tamoxifen estrogen cancer breast apoptosis by Zephyrus on 2009-09-03 17:51:36 as
	The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women. [My Copy] Oncology reports, Vol. 22, No. 3. (September 2009), pp. 487-492. by Ji Young Y. Kim, Chang Suk S. Lee, Hye Ok O. Kim, et al.Yong Hwa H. Jo, Juhie Lee, Min Hyung H. Jung, Hyung Hwan H. Baik, Wonchae Choe, Insug Kang, Kyung-Sik S. Yoon posted to tamoxifen polymorphism breast-cancer aromatase-inhibitor by Mi-Seon on 2009-08-12 08:59:18 as along with 1 person and 1 group ilsun Asian Pharmacogenetics Library
	The CYP2D64 polymorphism affects breast cancer survival in tamoxifen users. [My Copy] Breast cancer research and treatment* (3 February 2009) by Monique J. Bijl, Ron H. van Schaik, Laureen A. Lammers, et al.Albert Hofman, Arnold G. Vulto, Teun van Gelder, Bruno H. Stricker, Loes E. Visser posted to tamoxifen polymorphism cyp2d64 breast-cancer by Mi-Seon on 2009-08-12 08:47:30 as
	Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen [My Copy] BMC Genomics, Vol. 9, No. 1. (22 May 2008), 239. by Sherene Loi, Benjamin H. Kains, Christine Desmedt, et al.Pratyaksha Wirapati, Francoise Lallemand, Andrew Tutt, Cheryl Gillet, Paul Ellis, Kenneth Ryder, James Reid, Maria Daidone, Marco Pierotti, Els Berns, Maurice Jansen, John Foekens, Mauro Delorenzi, Gianluca Bontempi, Martine Piccart, Christos Sotiriou posted to microarray-data-analysis microarray-data estrogen-receptor breast-cancer tamoxifen by frohike on 2009-08-03 22:21:26 as along with 1 person jfr
	Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer. [My Copy] Carcinogenesis, Vol. 27, No. 11. (15 November 2006), pp. 2201-2208. by M. Wirtenberger, S. Tchatchou, K. Hemminki, et al.J. Schmutzhard, C. Sutter, R. K. Schmutzler, A. Meindl, B. Wappenschmidt, M. Kiechle, N. Arnold, B. H. Weber, D. Niederacher, C. R. Bartram, B. Burwinkel posted to breast-cancer ep300 genetic-variation polymorphism ppargc1a ppargc1b tamoxifen by Mi-Seon on 2009-07-30 01:25:31 as
	Association between CYP2D6 10 genotype and survival of breast cancer patients receiving tamoxifen treatment. [My Copy] Annals of oncology : official journal of the European Society for Medical Oncology / ESMO*, Vol. 19, No. 8. (1 August 2008), pp. 1423-1429. by Y. Xu, Y. Sun, L. Yao, et al.L. Shi, Y. Wu, T. Ouyang, J. Li, T. Wang, Z. Fan, T. Fan, B. Lin, L. He, P. Li, Y. Xie posted to breast-cancer cyp2d610 genotype survival tamoxifen by Mi-Seon on 2009-07-29 02:39:45 as along with 2 people and 1 group panwei misonneh Asian Pharmacogenetics Library
	The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen. [My Copy] Breast cancer research and treatment, Vol. 101, No. 1. (January 2007), pp. 113-121. by M. P. Goetz, S. K. Knox, V. J. Suman, et al.J. M. Rae, S. L. Safgren, M. M. Ames, D. W. Visscher, C. Reynolds, F. J. Couch, W. L. Lingle, R. M. Weinshilboum, E. G. Fritcher, A. M. Nibbe, Z. Desta, A. Nguyen, D. A. Flockhart, E. A. Perez, J. N. Ingle posted to 2d6 breast-cancer cytochrome-p450 pharmacogenetics tamoxifen by Mi-Seon on 2009-07-28 07:09:09 as
	Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis. [My Copy] Journal of the National Cancer Institute, Vol. 100, No. 9. (7 May 2008), pp. 642-648. by Rinaa S. Punglia, Harold J. Burstein, Eric P. Winer, Jane C. Weeks posted to aromatase-inhibitor breast-cancer disease-free-survival endocrine-therapy tamoxifen by Mi-Seon on 2009-07-28 07:02:44 as along with 1 person misonneh
	A Polymorphism in the TC21 Promoter Associates with an Unfavorable Tamoxifen Treatment Outcome in Breast Cancer [My Copy] Cancer Res, Vol. 68, No. 23. (1 December 2008), pp. 9799-9808. by Matjaz Rokavec, Werner Schroth, Sandra M. C. Amaral, et al.Peter Fritz, Lydia Antoniadou, Damjan Glavac, Wolfgang Simon, Matthias Schwab, Michel Eichelbaum, Hiltrud Brauch posted to breast-cancer outcome polymorphism tamoxifen by Mi-Seon on 2009-07-27 09:39:04 as
	Pharmacogenetics of Tamoxifen Biotransformation Is Associated With Clinical Outcomes of Efficacy and Hot Flashes [My Copy] J Clin Oncol, Vol. 23, No. 36. (20 December 2005), pp. 9312-9318. by Matthew P. Goetz, James M. Rae, Vera J. Suman, et al.Stephanie L. Safgren, Matthew M. Ames, Daniel W. Visscher, Carol Reynolds, Fergus J. Couch, Wilma L. Lingle, David A. Flockhart, Zeruesenay Desta, Edith A. Perez, James N. Ingle posted to outcome polymorphism tamoxifen by Mi-Seon on 2009-07-27 09:33:17 as
	CYP2D6 and tamoxifen: DNA matters in breast cancer [My Copy] Nat Rev Cancer, Vol. 9, No. 8. (August 2009), pp. 576-586. by Janelle M. Hoskins, Lisa A. Carey, Howard L. Mcleod posted to breast cyp2d6 pharmacogenetics resistance review tamoxifen by misonneh on 2009-07-27 08:49:07 as
	"Dwarf" Estrogen Receptor in Breast Cancer and Resistance to Tamoxifen [My Copy] J Clin Oncol, Vol. 27, No. 21. (20 July 2009), pp. 3413-3415. by Amy M. Fowler, Richard J. Santen, D. Craig Allred posted to alternative breast esr1 moa resistance splicing tamoxifen by misonneh on 2009-07-17 05:33:49 as
	Essential Role of Ubiquitin-Specific Protease 8 for Receptor Tyrosine Kinase Stability and Endocytic Trafficking In Vivo [My Copy] Mol. Cell. Biol., Vol. 27, No. 13. (1 July 2007), pp. 5029-5039. by Sandra Niendorf, Alexander Oksche, Agnes Kisser, et al.Jurgen Lohler, Marco Prinz, Hubert Schorle, Stephan Feller, Marc Lewitzky, Ivan Horak, Klaus-Peter Knobeloch posted to mefs tamoxifen ubc by kkgreenwood on 2009-07-15 02:44:32 as

Note: You may cite this page as: http://www.citeulike.org/tag/tamoxifen

Result page: 1 2 3 Next

breast	105
cancer	54
breast_cancer	39
resistance	35
pharmacogenetics	33
cyp2d6	28
review	23
breast-cancer	19
estrogen	19
thelist	13
therapy	13
er	11
polymorphism	11
receptor	11
moa	10
classification	8
genotype	8
oestrogen	8
comments	7
epigenetics	7
hormone	7
brca	6
chemotherapy	6
estrogen-receptor	6
genetics	6
mcf-7	6
methylation	6
prognosis	6
mapk	5
marker	5
modeling	5
survival	5
2d6	4
aromatase-inhibitor	4
ddi	4
era	4
erbb2	4
esr1	4
gene-expression	4
genetic-variation	4
hot_flash	4
mirna	4
outcome	4
prediction	4
prevention	4
progression	4
tempreg	4
17b-oestradiol	3
adr	3
anti-oestrogen	3
apoptosis	3
egf	3
gene_specific_methylation	3
markers	3
negative	3
pathway	3
phosphorylation	3
pk	3
positive	3
serine118	3
sult1a1	3
superlist	3
182780	2
ceacam6	2
chemoprevention	2
cyp2d610	2
cyp2d64	2
cyp450	2
disease-free-survival	2
distribution	2
dynamic	2
egfr	2
egfr_pathway	2
endocrine-therapy	2
ep300	2
erk	2
fat	2
gene_expression_signature	2
her2	2
igf	2
immunomodulation	2
insulin	2
invivo	2
macroautophagy	2
menopause	2
meta_analysis	2
metastasis	2
microrna	2
mirna221	2
mirna222	2
molecular	2
mrnaarray	2
pax2	2
pi3k	2
ppargc1b	2
recurrence	2
signal	2
signature	2
ugt	2
ugt2b15	2

Tag tamoxifen [137 articles] Export

Related Tags